CRC for Mental Health Ltd;Montana State University
发明人:
Blaine Roberts,Edward A. Dratz,Scott Laffoon
申请号：
US15880303
公开号：
US20180267063A1
申请日:
2018.01.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides methods for identifying biomarkers of disease capable of affecting cognitive function. The biomarkers identified by the methods of the prevention may be used for predicting whether a mammal will develop a disease capable of affecting cognitive function. More specifically, the present invention relates to the identification of biomarkers predictive of neurological diseases in a mammal and the use of these biomarkers in the diagnosis, differential diagnosis, and/or prognosis of the neurological disease. The methods and systems provided enable an assessment and theoretical prediction of neocortical amyloid loading based on the measurement of biomarkers that will provide an indication of whether a mammal is likely to develop a neurological disease.
